NEXTURNBIOSCIENCE Co., Ltd.

KOSDAQ:A089140 Rapporto sulle azioni

Cap. di mercato: ₩38.9b

NEXTURNBIOSCIENCE Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Young-Hwa Jung

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

Aug 13
Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Mar 28
NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Jan 25
Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

AMMINISTRATORE DELEGATO

Young-Hwa Jung (65 yo)

no data

Mandato

Mr. Jung Young-Hwa serves as the Chief Executive Officer of NexturnBioscience Co., Ltd (formerly known as Nexturn Co.,Ltd.)